** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)
** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322) ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-623322)

Public Alert No. 011/2026 – Alert on the Counterfeit Version of VISITECT HIV Advanced Disease Test Kits Identified in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) is warning healthcare providers, patients, and the public about reports of counterfeit and parallel-imported unregistered versions of the VISITECT HIV Advanced Disease Test Kits circulating in Nigeria. The Marketing Authorization Holder (MAH) of the products (EURO SPECS International Nigeria Limited) has confirmed the existence […]

Public Alert No. 010/2026- Alert on Notice of Concern Issued by Who for Meril Diagnostics Pvt Ltd

The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers, patients, and the public of the Notice of Concern (NOC) issued by the WHO Prequalification Service for some NAFDAC-registered medical devices manufactured by Meril Diagnostics Pvt. Ltd, India. The NOC was issued following significant violations observed during the WHO Prequalification […]

Public Alert No. 09/2026 – Public Reminder of NAFDAC’s Regulatory Directive on the Discontinued Registration of Multi-Dose Artemether /Lumefantrine Dry Powder for Oral Suspension

The National Agency for Food and Drugs Administration and Control (NAFDAC) is reminding the public of the Regulatory Directive issued last year on the discontinued registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for Oral Suspension due to the instability of the reconstituted formulations, which results in the loss of efficacy of the suspension. See Public […]

Public Alert No. 08/2026 – Danone Nutricia Recalls Several Batches of Aptamil and Cow and Gate First Infant Milk and Follow-on Milk Formula Products Due To Potential Contamination with Cereulide Toxin

The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the general public, healthcare professionals, caregivers, and all relevant stakeholders about the precautionary recall of Aptamil 1 From Birth First infant milk and Follow-on milk formula by Danone Nutricia due to potential contamination with cereulide. Cereulide is a toxin produced by the bacterium, Bacillus cereus, […]

Public Alert No. 07/2026- Alert on Surveillance and mop up of Counterfeit Dostinex (0.5mg) Tablets Found in Circulation

The National Agency for Food and Drug Administration and Control (NAFDAC) is warning healthcare providers, patients, and the public about the falsification and parallel importation of three batches of a NAFDAC-registered product: Dostinex 0.5mg Tablets. Pfizer Nigeria Ltd, the Marketing Authorization Holder (MAH) of the products, has confirmed the presence of falsified and parallel unregistered […]

Public Alert No. 06/2026 – Alert on Revalidated Infant Formula (SMA Gold) Found on Sale

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers, caregivers, and the public about a report of a suspected revalidated SMA Gold First Infant Milk Formula (900g) found for sale in Kaduna State, Nigeria. The product allegedly caused gastrointestinal distress in a 4-month-old infant following consumption. Physical examination of […]

Public Alert No. 05/2026 – Alert on the Mop-up of Counterfeit Dermazin (1% Silver Sulphadiazine) Cream

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers and the public about the circulation of counterfeit Dermazin (1% Silver Sulphadiazine) Cream. NAFDAC received a complaint from the legitimate Marketing Authorization Holder, Taylek Drugs Company Limited, concerning the sale of this counterfeit product. The packaging of the falsified Dermazin […]

💬